Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Roflumilast
Related studies linked through entity extraction aliases.
Roflumilast Plus Montelukast in Adults With Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis
- Status
- TERMINATED
- Phase
- PHASE2
Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease
- Status
- TERMINATED
- Phase
- PHASE2
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE4
Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- NA
Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease
- Status
- TERMINATED
- Phase
- PHASE2
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
- Status
- COMPLETED
- Phase
- PHASE4
Roflumilast and Cognition
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)
- Status
- COMPLETED
- Phase
- PHASE4
A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore:
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study
- Status
- COMPLETED
- Phase
- PHASE2